3 unknown, 1 recruiting. 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow Mabscale, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira® Adalimumab, Humira - Plaque Psoriasis | Phase 3 | Unknown | Mabscale, LLC | 494 | 2023-10-02 | 2023-11-29 |
| Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man Pertuzumab, Perjeta® - Healthy Men | Phase 1 | Unknown | Mabscale, LLC | 114 | 2023-07-20 | 2024-08-16 |
| Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis Rituximab, MabThera® - Rheumatoid Arthritis | Phase 1 | Unknown | Mabscale, LLC | 208 | 2023-06-14 | 2024-09-19 |
| A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer Bevacizumab, Paclitaxel, Carboplatin - Non-Small Cell Lung Cancer | Phase 3 | Recruiting | Mabscale, LLC | 620 | 2023-05-31 | 2024-08-16 |
Arthritis, Rheumatoid (1) · Carcinoma, Non-Small-Cell Lung (1)
Adalimumab (1) · Bevacizumab (1) · Carboplatin (1) · Paclitaxel (1) · Rituximab (1) · pertuzumab (1)
Russia (4)